
325: Biden's health care AI czar, a new obesity company, and its dealmaking CEO
The Readout Loud
Progress and Challenges in Drug Development
This chapter examines a company's journey in drug development, highlighting a lead molecule set for phase three trials and the competitive landscape. It also explores the leadership's ambitions that go beyond just leisure, indicating a strong commitment to market advancement.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.